Ajay Juneja

See how food affects your health.

Mood is making high-quality mental health care affordable, convenient, and accessible to all. By using technology to connect individuals with experts in psychiatry and therapy, Mood puts authentic human relationships at the center of the care experience. This results in positive long-term outcomes for clinicians and the people they care for.

Applied Cognition is a clinical stage platform therapeutic company that is first to advance the biology of brain glymphatic function to medical care. Enhancing glymphatic function is a novel approach to preventing progression of neurodegenerative disorders, demonstrated in animal models in several recent papers in leading scientific journals. The Company is the first to develop the ability to continuously measure the function of this important system in humans and to enhance its function using its patent-pending drug asset.

aptihealth is improving higher acuity behavioral healthcare for underserved populations—one member at a time. The company’s virtual-first model and proprietary screening, assessment, and treatment programs give members fast, convenient access to precise, personalized care. Headquartered in Boston and employing over 150, aptihealth has raised over $65 million in funding from leading international equity firms. The company’s care program and data insights are driving breakthroughs in mental health understanding, treatment, outcomes, and cost reduction. Learn more at www.aptihealth.com.

Mightier is a child-centered, evidence-based digital program that uses biometric feedback and game-based play to help children learn, practice, and apply lifelong coping skills. With both online and offline activities, Mightier supports the development of the whole child so kids can live healthier, happier lives. Developed at Boston Children’s Hospital and Harvard Medical School, Mightier is clinically proven to help kids ages 6 to 14 prepare for life's big emotions. To date, more than 2.5 million games have been played on the Mightier app by more than 100,000 kids. Mightier for Business provides employers, health plans and digital health partners with a solution by delivering immediate access to pediatric mental health services. Designed to complement existing employee mental health resources, Mightier for Business includes expanded support and services packages to support businesses and their employees.

Decisions on patient healthcare have been stripped away from patients and their medical providers. At Peachy, we equip patients and their medical providers to take back control of the entire patient healthcare experience.

Centenara Labs is a clinical-stage biotechnology company creating therapies to improve healthy aging. Its experienced drug discovery and development team applies a deep understanding of the biology of aging, alongside technological advances in biopharmaceutical R&D, to progress a new generation of medicines that will help people to age better and live longer.

What If Ventures began as a passion project to fund Mental Health startups. As the firm scaled to more than $100mm AUM and 4,000 LPs, the investment thesis has broadened to include a number of verticals with a core focus on Health and Freedom. We are a group of 4,000 passionate individuals funding cutting edge solutions to the worlds biggest problems. We fund solutions targeting the most stigmatized healthcare indications and some of the most difficult industrial and commercial problems facing society today. Our syndicate members are angel investors, family offices, healthcare providers, donor advised funds, and individuals who have been impacted personally by the problems we aim to help solve. We invest in startups from Seed to Pre-IPO. We accept investors of all shapes, sizes, walks of life and interests. Please get in touch if you would like to learn more.

Were a mental health organization committed to broadening access to therapy and psychiatry through insurance-covered services and virtual care. We believe mental health care should be accessible to those who want and need it, which is why were in network with most major insurance carriers. Our providers are licensed professionals who dedicate their time to Foresight members, our patients. Whether you’re feeling anxious or depressed, dealing with unresolved trauma or grief, or struggling with a relationship, we work to find the provider that’s your best fit. With us, you get all the benefits of traditional therapy or psychiatry and a team that helps you navigate your journey.

Founded in 2021, Velocity Capital Management is an operationally intensive private equity firm investing across the Sports, Media, and Entertainment sectors. Led by industry veterans David Abrams, Arne Rees, and Erin Edwards, who bring over 80 years of combined experience, we leverage relationships and expertise to transform IP-driven companies, unlocking growth, efficiency, and exceptional value across SME.

See how food affects your health.

Mood is making high-quality mental health care affordable, convenient, and accessible to all. By using technology to connect individuals with experts in psychiatry and therapy, Mood puts authentic human relationships at the center of the care experience. This results in positive long-term outcomes for clinicians and the people they care for.

Blackrock Neurotech is a team of the world’s leading engineers, neuroscientists, and visionaries. Our mission is simple: We want people with neurological disorders to walk, talk, see, hear, and feel again. We’re engineering the next generation of neural implants, including implantable brain-computer interface technology that restores function and independence to individuals with neurological disorders. Join us in changing lives today. Connect with us: Join Our Team | https://bit.ly/3bCsXRv LinkedIn | https://bit.ly/3PfifOL Twitter | https://bit.ly/3PfifOL Instagram | https://bit.ly/3bMaYrW Facebook | https://bit.ly/3JRc2av Clinical Trials | https://bit.ly/3A8QPWm Our site | https://blackrockneurotech.com Additional information: As the world leader in BCI tech, our pioneering neuroscience tools push the boundaries of research and empower innovation across more than 500+ global institutional partners, restoring function in patients suffering from neurological disease (ALS, Alzheimer’s, Parkinson’s), dysfunction (epilepsy, pain, brain trauma), and paralysis disorders. Our systems can be optimized from the ground up to handle even the most challenging applications. Our BCI is the most sophisticated and long-tested human BCI, interfacing with the brain and empowering independence in those with paralysis & other neurological disorders since 2004. In fact, dozens of patients have used our BCI for a collective 30,000+ days to regain freedom through movement and communication. Our first commercial BCI, MoveAgain, received a Breakthrough Designation from the FDA in 2021 and is expected to be commercially available in 2023. Join us in changing lives today.

Applied Cognition is a clinical stage platform therapeutic company that is first to advance the biology of brain glymphatic function to medical care. Enhancing glymphatic function is a novel approach to preventing progression of neurodegenerative disorders, demonstrated in animal models in several recent papers in leading scientific journals. The Company is the first to develop the ability to continuously measure the function of this important system in humans and to enhance its function using its patent-pending drug asset.